The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism

被引:353
作者
Hsu, KC
Chida, S
Dupont, B
Geraghty, DE
机构
[1] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Immunogenet Lab, Program Immunol, New York, NY 10021 USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
关键词
D O I
10.1034/j.1600-065X.2002.19004.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent genetic studies have established that the killer cell immunoglobulin-like receptor (KIR) genomic region displays extensive diversity through variation in gene content and allelic polymorphism within individual KIR genes. It is demonstrated by family segregation analysis, genomic sequencing, and gene order determination that genomic diversity by gene content alone gives rise to more than 20 different KIR haplotypes and at least 40-50 KIR genotypes. In the most reductionist format, KIR haplotypes can be accommodated within one of 10 different prototypes, each with multiple permutations. Our haplotype model considers the KIR haplotype as two separate halves: the centromeric half bordered upstream by KIR3DL3 and downstream by 2DL4, and the telomeric half bordered upstream by 2DL4 and downstream by 3DL2. There are rare KIR haplotypes that do not fit into this model. Recombination, gene duplication, and inversion can however, readily explain these haplotypes. Additional allelic polymorphism imposes extensive individual variability. Accordingly, this segment of the human genome displays a level of diversity similar to the one observed for the human major histocompatibility complex. Recent application of immunogenetic analysis of KIR genes in patient populations implicates these genes as important genetic disease susceptibility factors.
引用
收藏
页码:40 / 52
页数:13
相关论文
共 88 条
  • [21] Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires
    Crum, KA
    Logue, SE
    Curran, MD
    Middleton, D
    [J]. TISSUE ANTIGENS, 2000, 56 (04): : 313 - 326
  • [22] DANDREA A, 1995, J IMMUNOL, V155, P2306
  • [23] A NATURAL-KILLER-CELL RECEPTOR-SPECIFIC FOR A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULE
    DANIELS, BF
    KARLHOFER, FM
    SEAMAN, WE
    YOKOYAMA, WM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) : 687 - 692
  • [24] Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
    Diefenbach, A
    Jamieson, AM
    Liu, SD
    Shastri, N
    Raulet, DH
    [J]. NATURE IMMUNOLOGY, 2000, 1 (02) : 119 - 126
  • [25] Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
    Diefenbach, A
    Jensen, ER
    Jamieson, AM
    Raulet, DH
    [J]. NATURE, 2001, 413 (6852) : 165 - 171
  • [26] Crystal structure of the human natural killer cell inhibitory receptor KIR2DLI-HLA-Cw4 complex
    Fan, QR
    Long, EO
    Wiley, DC
    [J]. NATURE IMMUNOLOGY, 2001, 2 (05) : 452 - 460
  • [27] KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential
    Faure, M
    Long, EO
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (12) : 6208 - 6214
  • [28] Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
    Flores-Villanueva, PO
    Yunis, EJ
    Delgado, JC
    Vittinghoff, E
    Buchbinder, S
    Leung, JY
    Uglialoro, AM
    Clavijo, OP
    Rosenberg, ES
    Kalams, SA
    Braun, JD
    Boswell, SL
    Walker, BD
    Goldfeld, AE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) : 5140 - 5145
  • [29] Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism
    Gardiner, CM
    Guethlein, LA
    Shilling, HG
    Pando, M
    Carr, WH
    Rajalingam, R
    Vilches, C
    Parham, P
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 2992 - 3001
  • [30] GASSNER C, IN PRESS GENOMICS